Tinnitus clinical trial: we are now recruiting for a Phase IIa clinical trial in the UK. Find out more and sign up for our Tinnitus clinical trial

Tinnitus Clinical Trial - Information

RECRUITMENT CLOSED​ - SEE NEWS SECTION

Autifony, along with Innovate UK (previously known as the UK Technology Strategy Board), is sponsoring a Phase IIa tinnitus clinical trial in the UK. Professor Jaydip Ray, ENT Surgeon at Sheffield Teaching Hospitals & Sheffield Children's Hospital, is the national Coordinating Investigator for this clinical trial. Our lead academic collaborator is the University of Nottingham (Professor Deborah Hall). This "proof-of-concept" study will explore the potential of Autifony's lead Kv3 modulator, AUT00063, to reduce the symptoms of tinnitus in people who have subjective tinnitus.

18 key Hospital sites across the UK were opened for this tinnitus clinical trial. For more detailed information on these sites see here. For more information and Frequently Asked Questions, see here.  

Further information on this tinnitus clinical trial is also available at Clinicaltrials.gov

If you need more information about tinnitus, or advice on managing tinnitus, then please contact the British Tinnitus Association (www.tinnitus.org.uk), or call their helpline on the numbers below:

0800 018 0527 free of charge - from within the UK only
0114 250 9922 national rate within the UK
+44 114 250 9922 outside the UK